Related Experiment Video
Updated: May 16, 2026
07:48
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Summary
The California Institute of Quantitative Biosciences bridges the gap between scientific discovery and commercialization through its biotechnology incubator programs. These initiatives accelerate the translation of research into market-ready innovations.
Area of Science:
- Biotechnology
- Biosciences
- Innovation Management
Background:
- The biotechnology sector faces challenges in translating scientific discoveries into commercially viable products.
- Bridging the gap between research and market entry is crucial for economic growth and public benefit.
Discussion:
- The California Institute of Quantitative Biosciences (QB3) provides essential resources and programs to support biotechnology commercialization.
- Incubator programs foster collaboration and provide infrastructure for early-stage biotech ventures.
Key Insights:
- QB3's initiatives are designed to accelerate the development pipeline from laboratory discovery to market.
- These programs facilitate the transition of novel biotechnologies into practical applications.
Outlook:
- Continued investment in biotech incubators can drive significant advancements in healthcare, agriculture, and industry.
- QB3's model offers a framework for other institutions seeking to enhance biotech commercialization efforts.
Related Concept Videos
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:23Characteristics of Life
Biology is a natural science that studies life and living organisms, including their structure, function, development, interactions, evolution, distribution, and taxonomy. The field's scope is extensive and divided into several specialized disciplines, such as anatomy, physiology, ethology, genetics, and many more. All living things share a few key traits, including cellular organization, heritable genetic material and the ability to adapt/evolve, metabolism to regulate energy needs, the...